{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:03:58Z","timestamp":1775509438032,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T00:00:00Z","timestamp":1246579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000423","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T21:32:44Z","timestamp":1246570364000},"page":"e1000423","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":278,"title":["Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis"],"prefix":"10.1371","volume":"5","author":[{"given":"Sarah L.","family":"Kinnings","sequence":"first","affiliation":[]},{"given":"Nina","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Nancy","family":"Buchmeier","sequence":"additional","affiliation":[]},{"given":"Peter J.","family":"Tonge","sequence":"additional","affiliation":[]},{"given":"Lei","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Philip E.","family":"Bourne","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"ref1","article-title":"Tuberculosis Fact sheet N\u00b0104 - Global and regional incidence.","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/138945007780058942","article-title":"Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents.","volume":"8","author":"JS Oliveira","year":"2007","journal-title":"Curr Drug Targets"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M211968200","article-title":"Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data.","volume":"278","author":"MR Kuo","year":"2003","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nm0307-295","article-title":"From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.","volume":"13","author":"SE Dorman","year":"2007","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases.","volume":"5","author":"S Nwaka","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nrd1900","article-title":"Finding new tricks for old drugs: an efficient route for public-sector drug discovery.","volume":"4","author":"KA O'Connor","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/jm030912m","article-title":"Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.","volume":"47","author":"A Weber","year":"2004","journal-title":"J Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nbt1228","article-title":"Global mapping of pharmacological space.","volume":"24","author":"GV Paolini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm030480f","article-title":"Selective optimization of side activities: another way for drug discovery.","volume":"47","author":"CG Wermuth","year":"2004","journal-title":"J Med Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1359-6446(05)03686-X","article-title":"Selective optimization of side activities: the SOSA approach.","volume":"11","author":"CG Wermuth","year":"2006","journal-title":"Drug Discov Today"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1073\/pnas.0704422105","article-title":"Detecting evolutionary relationships across existing fold space, using sequence order-independent profile\u2013profile alignments.","volume":"105","author":"L Xie","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pcbi.0030217","article-title":"In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators.","volume":"3","author":"L Xie","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2105-8-S4-S9","article-title":"A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites.","volume":"8","author":"L Xie","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1000387","DOI":"10.1371\/journal.pcbi.1000387","article-title":"Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.","volume":"5","author":"L Xie","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"i305","DOI":"10.1093\/bioinformatics\/btp220","article-title":"A unified statistical model to support local sequence order independent similarity searching for ligand binding sites and its application to genome-based drug discovery.","volume":"25","author":"L Xie","year":"2009","journal-title":"Bioinformatics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.","volume":"18","author":"K Takayama","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.","volume":"263","author":"A Banerjee","year":"1994","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20062100","article-title":"Mechanism of thioamide drug action against tuberculosis and leprosy.","volume":"204","author":"F Wang","year":"2007","journal-title":"J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","article-title":"Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.","volume":"15","author":"X He","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1021\/jm060715y","article-title":"Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.","volume":"49","author":"X He","year":"2006","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/cb0500042","article-title":"High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.","volume":"1","author":"TJ Sullivan","year":"2006","journal-title":"ACS Chem Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00023210-200519020-00006","article-title":"Tolcapone: a review of its use in the management of Parkinson's disease.","volume":"19","author":"GM Keating","year":"2005","journal-title":"CNS Drugs"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1021\/jm020050+","article-title":"Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI).","volume":"45","author":"WH Miller","year":"2002","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10822-007-9159-2","article-title":"An improved relaxed complex scheme for receptor flexibility in computer-aided drug design.","volume":"22","author":"RE Amaro","year":"2008","journal-title":"J Comput Aided Mol Des"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"17278","DOI":"10.1073\/pnas.0805820105","article-title":"Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei.","volume":"105","author":"RE Amaro","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1023\/B:JCAM.0000021831.47952.a7","article-title":"A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods.","volume":"17","author":"AJ Tervo","year":"2003","journal-title":"J Comput Aided Mol Des"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"ref28","article-title":"Encyclopedia of Pharmaceutical Technology: Informa HealthCare.","author":"J Swarbrick","year":"2006"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1074\/jbc.274.22.15582","article-title":"Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.","volume":"274","author":"DA Rozwarski","year":"1999","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/ar700156e","article-title":"Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.","volume":"41","author":"H Lu","year":"2008","journal-title":"Acc Chem Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","article-title":"Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.","volume":"15","author":"X He","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/jm0204035","article-title":"Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.","volume":"46","author":"MA Seefeld","year":"2003","journal-title":"J Med Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00002018-200326110-00001","article-title":"Tolcapone-related liver dysfunction: implications for use in Parkinson's disease therapy.","volume":"26","author":"N Borges","year":"2003","journal-title":"Drug Saf"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mds.870100521","article-title":"A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease.","volume":"10","author":"GK Wenning","year":"1995","journal-title":"Mov Disord"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.47.9.2903-2913.2003","article-title":"Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis.","volume":"47","author":"JC Betts","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1289\/ehp.10727","article-title":"Compound cytotoxicity profiling using quantitative high-throughput screening.","volume":"116","author":"M Xia","year":"2008","journal-title":"Environ Health Perspect"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neuropharm.2003.10.015","article-title":"Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells.","volume":"46","author":"LV Korlipara","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery.","volume":"4","author":"AL Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts.","volume":"12","author":"GR Zimmermann","year":"2007","journal-title":"Drug Discov Today"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank.","volume":"28","author":"HM Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmgm.2006.06.002","article-title":"eHiTS: A new fast, exhaustive flexible ligand docking system.","volume":"26","author":"Z Zsoldos","year":"2007","journal-title":"J Mol Graph Model"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10822-007-9114-2","article-title":"Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search.","volume":"21","author":"AN Jain","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"D233","DOI":"10.1093\/nar\/gki057","article-title":"The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema.","volume":"33","author":"N Deshpande","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration.","volume":"34","author":"DS Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.","volume":"25","author":"SF Altschul","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2013a free database of commercially available compounds for virtual screening.","volume":"45","author":"JJ Irwin","year":"2005","journal-title":"J Chem Inf Model"},{"key":"ref47","article-title":"R: A Language and Environment for Statistical Computing","author":"RDC Team","year":"2007"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1046\/j.1365-2958.2003.03416.x","article-title":"Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics.","volume":"47","author":"NA Buchmeier","year":"2003","journal-title":"Mol Microbiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.2235848100","article-title":"The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.","volume":"100","author":"R Rawat","year":"2003","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T05:53:38Z","timestamp":1558418018000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000423"}},"subtitle":[],"editor":[{"given":"James M.","family":"Briggs","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,7,3]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000423","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,3]]}}}